glp 1 work Mechanisms by which GLP-1 agonists may exert beneficial effects on the GLP-1 Therapy Part 1: Setting

Abbreviations GLP-1RAs: Glucagon-like peptide-1 receptor agonists T2DM: Type 2 diabetes mellitus DPP-4: Dipeptidyl peptidase IV GLP-1R: Glucagon-like peptide-1 receptor cAMP: Cyclic adenosine monophosphate PKA: Protein kinase A PI3K: Phosphatidylinositol 3-kinase Akt: Protein kinase B AD: Alzheimers diseases TRPV1: Transient receptor potential vanilloid 1 OA: Osteoarthritis KOA: Knee OA MIA: Monoiodoacetate IL-6: Interleukin 6 PGE2: Prostaglandin E2 NO: Nitric oxide ER: Endoplasmic reticulum IL-1: Interleukin-1 MMP-3: Matrix metalloproteinases-3 MMP-13: Matrix metalloproteinases-13 ROS: Reactive oxygen species BMI: Body mass index IBS: Irritable bowel syndrome ATP: Adenosine triphosphate SERT: Serotonin transporter TPH-1: Tryptophan hydroxylase-1 AC: Adenylate cyclase LPS: Lipopolysaccharide WAS: Water avoidance stress IBS-C: Constipation-predominant IBS SNL: Spinal nerve ligation SCI: Spinal cord injury CHOP: C/EBP homologous transcription factor protein GRP78: Glucose regulatory protein 78 PSNT: Partial sciatic nerve transection L

Guide to emoji hyperlinks = Link to online calculator

Clarke, R

Peptide therapy and hormone replacement are not identical

& Weiss, R

This has been achieved through techniques such as peptide sequence modification, peptide lipidation, albumin fusion, and Fc fusion